Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma ; volume:17 ; number:1 ; day:21 ; month:3 ; year:2020 ; pages:1-5 ; date:12.2020
Retrovirology ; 17, Heft 1 (21.3.2020), 1-5, 12.2020
- Creator
-
Marçais, Ambroise
Cook, Lucy
Witkover, Aviva
Asnafi, Vahid
Avettand-Fenoel, Véronique
Delarue, Richard
Cheminant, Morgane
Sibon, David
Frenzel, Laurent
Thé, Hugues de
Bangham, Charles R. M.
Bazarbachi, Ali
Hermine, Olivier
Suarez, Felipe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12977-020-0513-y
- URN
-
urn:nbn:de:101:1-2020061321035393791248
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Marçais, Ambroise
- Cook, Lucy
- Witkover, Aviva
- Asnafi, Vahid
- Avettand-Fenoel, Véronique
- Delarue, Richard
- Cheminant, Morgane
- Sibon, David
- Frenzel, Laurent
- Thé, Hugues de
- Bangham, Charles R. M.
- Bazarbachi, Ali
- Hermine, Olivier
- Suarez, Felipe
- SpringerLink (Online service)
Other Objects (12)
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
ATO (Arsenic Trioxide) effects on promyelocytic leukemia nuclear bodies reveals antiviral intervention capacity
Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy
ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity
Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells
Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells
PML-RARA mutations confer varying arsenic trioxide resistance
Clinical Indicators of Hepatotoxicity in Newly Diagnosed Acute Promyelocytic Leukemia Patients Undergoing Arsenic Trioxide Treatment
Vitamin D3 potentiates the antitumorigenic effects of arsenic trioxide in human leukemia (HL-60) cells
Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
ATO (Arsenic Trioxide) effects on promyelocytic leukemia nuclear bodies reveals antiviral intervention capacity
Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy
ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity
Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells
Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells
PML-RARA mutations confer varying arsenic trioxide resistance
Clinical Indicators of Hepatotoxicity in Newly Diagnosed Acute Promyelocytic Leukemia Patients Undergoing Arsenic Trioxide Treatment
Vitamin D3 potentiates the antitumorigenic effects of arsenic trioxide in human leukemia (HL-60) cells
Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
ATO (Arsenic Trioxide) effects on promyelocytic leukemia nuclear bodies reveals antiviral intervention capacity
Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy
ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity
Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells
Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells
PML-RARA mutations confer varying arsenic trioxide resistance
Clinical Indicators of Hepatotoxicity in Newly Diagnosed Acute Promyelocytic Leukemia Patients Undergoing Arsenic Trioxide Treatment
Vitamin D3 potentiates the antitumorigenic effects of arsenic trioxide in human leukemia (HL-60) cells
Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report